CM Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

CM Management’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.47M	Hold	350,000	–	–	0.94%	45
2026 Q1	$1.23M	Buy	+350,000	New	+$1.43M	1.03%	38

Other funds holding IRWD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

CM Management's IRWD Position: Q2 2026 in Review

CM Management held its Ironwood Pharmaceuticals (IRWD) position steady in Q2 2026 at 350,000 shares worth $1.47M. The position accounts for 0.94% of the portfolio, ranked #45.

CM Management first reported a position in IRWD in Q1 2026 and has held it in 2 quarters since. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

CM Management held 350,000 shares of Ironwood Pharmaceuticals worth $1.47M as of Q2 2026.
CM Management left its Ironwood Pharmaceuticals share count unchanged in Q2 2026.
Ironwood Pharmaceuticals made up 0.94% of CM Management's portfolio in Q2 2026, its #45 holding.
CM Management first reported a position in Ironwood Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on CM Management's 13F filing for Q2 2026, filed 13 Aug 2026.